United States Pharmaceutical Cannabis Market was valued at USD 4.1 Billion in 2022 and is projected to reach USD 16.4 Billion by 2030, growing at a CAGR of 19.0% from 2024 to 2030.
The US Pharmaceutical Cannabis Market has been experiencing rapid growth, with increasing demand for medical cannabis products across the country. As more states legalize medical marijuana, industries are increasingly seeking reliable suppliers and solutions to meet the needs of consumers. The market includes a variety of cannabis-based products such as oils, edibles, tinctures, capsules, and topicals, catering to patients with chronic pain, anxiety, and other medical conditions.
One of the main drivers behind the market's growth is the rising acceptance of cannabis as a legitimate treatment option. The pharmaceutical cannabis market continues to expand with an increasing number of clinical trials showing the benefits of cannabis in treating various ailments. For example, cannabinoids like CBD and THC have been found to alleviate symptoms of conditions such as epilepsy, multiple sclerosis, and cancer, leading to greater demand from the medical community.
The pharmaceutical industry plays a significant role in shaping the US Pharmaceutical Cannabis Market by creating partnerships with cannabis producers to ensure quality and compliance with federal regulations. The demand for standardized, pharmaceutical-grade cannabis is crucial as companies work to develop safe and effective products for patients. This requirement has sparked innovation, with many companies developing cannabis strains tailored for specific medical conditions and introducing new extraction methods to maximize therapeutic benefits.
Industries within the pharmaceutical sector are increasingly looking for precision in cannabis dosage, which has led to the growth of pharmaceutical-grade formulations. This is where the demand for high-quality cannabis products becomes critical. Pharmaceutical companies need consistency, lab-tested products, and transparent labeling to ensure their customers receive safe and effective treatments.
The US Pharmaceutical Cannabis Market is also seeing significant investments from major players in the pharmaceutical industry. These companies are keen to tap into a growing market while ensuring they adhere to stringent regulatory frameworks. The demand for pharmaceutical cannabis has prompted increased lobbying efforts, with lawmakers pushing for clarity on federal cannabis policies, which could further fuel market growth.
Overall, the pharmaceutical cannabis sector is expanding rapidly, driven by both demand from patients and industries seeking regulated, high-quality products. With the right innovations and investments, the future of the US Pharmaceutical Cannabis Market looks promising.
Get an In-Depth Research Analysis of the US Pharmaceutical Cannabis Market Size And Forecast [2025-2032]
Â
Canopy Growth Corporation
GW Pharmaceuticals
plc
Aurora Cannabis
Inc.
Aphria
Inc.
MedReleaf Corporation
Insys Therapeutics
Inc.
CanniMed Therapeutics
Inc.
Cara Therapeutics
Inc.
United Cannabis Corporation
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Pharmaceutical Cannabis Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Pharmaceutical Cannabis Market
CBD Oil
THC Oil
Capsules & Tablets
Tinctures
Topicals (Lotions, Creams)
Edibles (Gummies, Chocolates)
Pain Management
Anxiety & Stress Relief
Neurological Disorders (Epilepsy, MS)
Oncology (Cancer-related symptoms)
Gastrointestinal Disorders (IBS, Crohn’s)
Sleep Disorders
Organic Cannabis
Conventional Cannabis
FDA-approved Strains
Genetically Modified Cannabis
Pharmacies
Online Retail
Specialized Clinics
Direct-to-Consumer Sales
Health and Wellness Stores
18-24 years
25-34 years
35-44 years
45-54 years
55 years and above
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharmaceutical Cannabis Market Research Analysis
1. Introduction of the US Pharmaceutical Cannabis Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Pharmaceutical Cannabis Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Pharmaceutical Cannabis Market, By Type
6. US Pharmaceutical Cannabis Market, By Application
7. US Pharmaceutical Cannabis Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Pharmaceutical Cannabis Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/